Abstract

Cardiorespiratory fitness is an independent risk factor for cardiovascular disease and shortened life expectancy in breast cancer survivors. This randomised controlled trial (n = 153) was designed for patients with a physically inactive lifestyle prediagnosis and concurrently referred to adjuvant chemotherapy. We compared two 12-week exercise interventions aimed at physiological and patient-reported outcomes (cardiorespiratory fitness, muscle strength, metabolic markers, physical activity, pain, fatigue), including a 39-week follow-up. A supervised hospital-based moderate to high intensity group exercise intervention was compared to an instructed home-based individual pedometer intervention. The two 12-week interventions included oncologists’ recommendations and systematic health counselling. Outcomes were measured at baseline and week 6, 12 and 39. Primary outcome cardiorespiratory fitness declined significantly during chemotherapy and was restored in both interventions at follow-up. The interventions effectively engaged breast cancer patients in sustaining physical activities during and following adjuvant treatment. A composite metabolic score improved significantly. Positive cardiorespiratory fitness responders had improved clinical effects on fatigue, pain and dyspnoea versus negative responders. We conclude that a loss of cardiorespiratory fitness among physically inactive breast cancer patients may be restored by early initiated interventions and by adapting to physical activity recommendations, leading to a decreased cardiovascular risk profile in breast cancer survivors.

Details

Title
Physical deterioration and adaptive recovery in physically inactive breast cancer patients during adjuvant chemotherapy: a randomised controlled trial
Author
Møller, Tom 1   VIAFID ORCID Logo  ; Andersen, Christina 2 ; Lillelund Christian 2 ; Bloomquist Kira 2 ; Christensen, Karl Bang 3 ; Ejlertsen Bent 4 ; Tuxen Malgorzata 4 ; Oturai, Peter 5 ; Breitenstein Ulla 4 ; Kolind Cecilie 6 ; Travis, Pernille 6 ; Bjerg, Tina 7 ; Rørth Mikael 7 ; Adamsen Lis 8 

 The University Hospitals Centre for Health Research (UCSF), Copenhagen University Hospital, Rigshospitalet, Department, Copenhagen, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public Health, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 The University Hospitals Centre for Health Research (UCSF), Copenhagen University Hospital, Rigshospitalet, Department, Copenhagen, Denmark (GRID:grid.5254.6) 
 University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public Health, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Copenhagen, Denmark (GRID:grid.5254.6) 
 Copenhagen University Hospital, Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen, Denmark (GRID:grid.5254.6) 
 Copenhagen University Hospital, Herlev Hospital, Department of Oncology, Herlev, Denmark (GRID:grid.411900.d) (ISNI:0000 0004 0646 8325) 
 Copenhagen University Hospital, Rigshospitalet, Department of Oncology, Copenhagen, Denmark (GRID:grid.411900.d) 
 The University Hospitals Centre for Health Research (UCSF), Copenhagen University Hospital, Rigshospitalet, Department, Copenhagen, Denmark (GRID:grid.411900.d); University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public Health, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2413787199
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.